Hypertrophic Cardiomyopathy (HCM) is an inherited genetic heart condition affecting hundreds of thousands of people around the globe and is the leading cause of sudden cardiac death in young adults. Together with leading HCM specialists, we bring you the "Heartbeats" series of educational podcasts discussing pathophysiology, diagnosis, management, genetics and the role of precision medicine to treat this chronic condition.
Heartbeats: A Conversation with The Hypertrophic Cardiomyopathy Experts
Dr. Matthew Roe, Faculty Director, Global Outcomes Commercial Megatrials, DCRI Fellowship Program Director, Duke University.
Dr. Eric Topol, Chief Academic Officer, Scripps Clinic; Director of Scripps Translational Science Institute; Gary and Mary West Chairman of Innovative Medicine; and Co-founder of West Wireless Health Institute.
Dr. Bernard Gersh, Professor of Medicine, Mayo Clinic College of Medicine; Consultant in Cardiac Diseases at the Mayo Clinic; and Co-chair of the ACC/AHA HCM Guidelines Committee.
Dr. Euan Ashley, Associate Professor of Cardiovascular Medicine, Genetics and Pathology, Stanford University Medical Center; Founding Director of the Stanford Center for Inherited Cardiovascular Disease.
Dr. Andrew Wang, Structural Heart Disease Specialist, Duke University Medical Center.
Dr. Martin Maron, Director, Hypertrophic Cardiomyopathy Center; Co-Director, Cardiac CT and MRI; Assistant Professor, Tufts University School of Medicine